211 related articles for article (PubMed ID: 13024096)
1. [Treatment of hyperthyroidism with methimazole].
PLAMONDON CA; WISWELL JG; ASPER SP
Laval Med; 1952 Nov; 17(9):1208-19. PubMed ID: 13024096
[No Abstract] [Full Text] [Related]
2. Experience with methimazole (tapazole) in the treatment of hyperthyroidism; a report of thirty-five cases.
HALLMAN BL; BONDY PK
Am J Med; 1951 Dec; 11(6):724-29. PubMed ID: 14902842
[No Abstract] [Full Text] [Related]
3. [Treatment of hyperthyroidism with 1-methyl-2-mercaptoimidazole].
KLEIN E; WIEDENMANN U
Dtsch Med Wochenschr; 1953 Jun; 78(24):877-8. PubMed ID: 13068021
[No Abstract] [Full Text] [Related]
4. Variations in the response of individuals of different ages to an antithyroid compound (methimazole).
McGAVACK TH; CHEVALLEY J; PEARSON S
J Am Geriatr Soc; 1955 Feb; 3(2):96-105. PubMed ID: 14353621
[No Abstract] [Full Text] [Related]
5. Clinical trial of methimazole in treatment of thyrotoxicosis.
DAVIDSON LA
Br Med J; 1953 Dec; 2(4849):1300-3. PubMed ID: 13106417
[No Abstract] [Full Text] [Related]
6. Methimazole and carbimazole in hyperthyroidism: a comparison by a double blind technique.
McGAVACK TH
Am J Med Sci; 1959 Jul; 238(1):1-12. PubMed ID: 13661169
[No Abstract] [Full Text] [Related]
7. [Experience with the thyroid antagonist favistan].
KLEINDL K
Med Klin; 1955 Apr; 50(15):672-4. PubMed ID: 14383176
[No Abstract] [Full Text] [Related]
8. [Treatment of hyperthyroidosis with 1-methyl-2-mercaptiomidazol (mercazole)].
WURTH K
Praxis; 1953 Apr; 42(17):331-3. PubMed ID: 13073811
[No Abstract] [Full Text] [Related]
9. [Experiences with 1-methyl-2-mercaptoimidazole (favistan)].
REIS H
Munch Med Wochenschr; 1955 Jul; 97(28):903-4. PubMed ID: 13265622
[No Abstract] [Full Text] [Related]
10. [Clinical experiences with 1-methyl-2-mercaptoimidazole in the treatment of thyrotoxicosis].
KILPINEN O
Duodecim; 1952; 68(11):967-71. PubMed ID: 13033768
[No Abstract] [Full Text] [Related]
11. A four-year study of the treatment of hyperthyroidism with methimazole.
CHEVALLEY J; McGAVACK TH; KENIGSBERG S; PEARSON S
J Clin Endocrinol Metab; 1954 Aug; 14(8):948-60. PubMed ID: 13183988
[No Abstract] [Full Text] [Related]
12. [Effectiveness of mercazolyl in thyrotoxicosis].
BARBA EI
Probl Endokrinol Gormonoter; 1957; 3(6):99-101. PubMed ID: 13527468
[No Abstract] [Full Text] [Related]
13. Agranulocytosis occurring during 1-methyl-2-mercaptoimidazole therapy treated with cortisone and donor bone marrow injection.
AINSLIE EH; HARLEY HC
Can Serv Med J; 1955; 11(7):502-8. PubMed ID: 13240627
[No Abstract] [Full Text] [Related]
14. Exacerbation of hyperthyroidism by methimazole during iodide therapy.
PROUT TE; ASPER SP
AMA Arch Intern Med; 1958 Feb; 101(2):364-8. PubMed ID: 13497338
[No Abstract] [Full Text] [Related]
15. Subclinical hyperthyroidism.
Parker L
N Engl J Med; 2002 Jan; 346(1):67-8. PubMed ID: 11778009
[No Abstract] [Full Text] [Related]
16. [Comparison of the treatment of thyrotoxicosis with thyronorman and methimazole].
LUFT
Z Gesamte Inn Med; 1960 Apr; 15():357-8. PubMed ID: 13853726
[No Abstract] [Full Text] [Related]
17. Propylthiouracil and methimazole therapy; comparative experiences.
IRWIN GW; VAN VACTOR HD; NORRIS MS
J Am Med Assoc; 1952 Aug; 149(18):1637-40. PubMed ID: 14945993
[No Abstract] [Full Text] [Related]
18. [Our experiences with ambulatory therapy of hyperthyroidism with favistan].
LEVNTAL Z; PUTNIK M; GLIGOROVA N
Med Glas; 1960 Feb; 14():140-3. PubMed ID: 14416352
[No Abstract] [Full Text] [Related]
19. [Immediate results with 1-methyl-2-mercaptoimidazole in hyperthyroidism].
ROJAS MUJICA G; DIAZ DE VALDES H
Rev Med Chil; 1952 Mar; 80(3):159-63. PubMed ID: 14942114
[No Abstract] [Full Text] [Related]
20. [Experiences with methimazole and carbimazole in the treatment of hyperthyroidism].
PULVER W; BRUNDLER R
Ther Umsch; 1957 Jan; 14(1):1-10. PubMed ID: 13409311
[No Abstract] [Full Text] [Related]
[Next] [New Search]